한글목차

인슐린 펜 시장 규모는 2024년에 60억 1,300만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 8.2%로 성장하여 2031년까지 105억 1,900만 달러에 이를 것으로 예측됩니다.

본 보고서는 인슐린 펜의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축에 대한 최근 관세 조정 및 국제적인 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.

인슐린 펜은 당뇨병 환자의 피하 인슐린 투여를 목적으로 하는 휴대형, 용량 조절형 의료기기입니다. 일반적으로 펜 본체와 교체 가능한 바늘로 구성되며, 기존의 바이알과 주사기를 사용하는 방법에 비해 사용자 친화적인 대안을 제공합니다. 인슐린 펜은 정확한 투약량, 사용 편의성, 휴대성, 환자의 복약 순응도 향상 등의 장점을 제공합니다. 일회용과 재사용이 가능하며, 1형 및 2형 당뇨병 관리를 위해 미리 채워진 카트리지와 함께 일반적으로 사용됩니다. 인슐린 펜은 만성질환 관리에 필수적인 도구로서 전 세계적으로 인슐린 치료의 표준화와 개별화를 가속화하고 있습니다.

세계적으로 당뇨병 유병률이 꾸준히 증가하면서 만성질환 관리에 대한 관심이 높아지는 가운데, 인슐린 펜은 치료 순응도를 높이고 투약을 간소화할 수 있는 주요 도구로 시장이 빠르게 성장하고 있습니다. 주요 제약사 및 의료기기 제조업체들은 환자와 의료 서비스 제공업체의 실시간 협업을 강화하기 위해 스마트 인슐린 펜, 디지털 통합 시스템 등 제품 혁신에 적극적으로 투자하고 있습니다. 특히 의료서비스가 충분하지 않은 지역에서는 1차의료 수준에서 표준화된 당뇨병 치료를 지원하는 정부 정책도 시장 침투를 촉진하고 있습니다.

기술적 진보에도 불구하고 인슐린 펜 산업은 여전히 몇 가지 과제가 남아있습니다. 일부 지역에서는 보험 적용 범위의 제한과 높은 본인 부담금이 여전히 보급의 장벽으로 작용하고 있습니다. 저가 제네릭 의약품의 경쟁은 오리지널 브랜드에 압력을 가하고 있습니다. 또한, 기기 호환성 및 표준화된 소모품 부족과 같은 문제는 국제적인 확장성을 제한할 수 있습니다. 세계 진출을 위해서는 규제 차이에 대한 대응과 운영 리스크를 줄이기 위한 견고한 공급망 구축도 필요합니다.

최종 사용자 수요는 수동적 치료에서 능동적 질병 관리로 전환되고 있습니다. 특히 젊은 층의 환자들은 스마트 모니터링과 원격 지원을 선호합니다. 인슐린 펜은 혈당 측정기, 모바일 앱과 함께 디지털 생태계에 통합되는 사례가 증가하고 있으며, 커넥티드 만성질환 관리로의 전환을 촉진하고 있습니다. 일회용 펜은 편의성 때문에 병원과 1차의료 현장에서의 채택이 확대되고 있습니다. 전 세계 고령화 추세에 따라 안전성, 사용 편의성, 추적성을 갖춘 인슐린 펜에 대한 수요가 증가하면서 시장의 다음 진화 단계를 주도할 것입니다.

이 보고서는 인슐린 펜 세계 시장에 대한 종합적인 분석을 제공하는 것을 목표로 합니다. 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율과 순위에 초점을 맞추어 지역별, 국가별, 유형별, 용도별 인슐린 펜 분석을 포함합니다.

인슐린 펜 시장 규모와 추정 및 예측은 판매량(천 개 단위)과 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도로 하여 2020년부터 2031년까지 과거 데이터와 예측 데이터를 포함하고 있습니다. 정량적, 정성적 분석을 통해 독자들이 인슐린 펜 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 지원합니다.

시장 세분화

기업별

• Novo Nordisk
• Eli Lilly
• Sanofi
• Embecta
• MDT Group
• Dongbao
• Owen Mumford
• Ganlee

유형별 부문

• 재이용 가능 인슐린 펜
• 일회용 인슐린 펜

용도별 부문

• 병원
• 진료소
• 약국

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for Insulin Pen was estimated to be worth US$ 6013 million in 2024 and is forecast to a readjusted size of US$ 10519 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Insulin Pen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

An insulin pen is a portable, dose-controlled medical device designed for subcutaneous insulin delivery in diabetes patients. Typically consisting of a pen body and a replaceable needle, it offers a user-friendly alternative to traditional vial-and-syringe methods. Insulin pens provide advantages such as accurate dosing, ease of use, portability, and enhanced patient adherence. They are available in both disposable and reusable forms and are commonly used with prefilled cartridges for Type 1 and Type 2 diabetes management. As an essential tool in chronic disease control, insulin pens are accelerating the standardization and personalization of insulin therapy worldwide.

With the global prevalence of diabetes rising steadily and chronic disease management gaining attention, insulin pens are experiencing rapid market growth as a key tool to improve treatment compliance and ease of administration. Leading pharmaceutical and medical device companies are actively investing in product innovation, including smart insulin pens and digitally integrated systems, to enhance real-time connectivity between patients and healthcare providers. Government policies supporting standardized diabetes care at the primary level are also expanding market penetration, particularly in underserved regions.

Despite technological advancements, several challenges remain in the insulin pen industry. In some regions, limited reimbursement coverage and high out-of-pocket costs still hinder widespread adoption. Price competition from low-cost generics is putting pressure on originator brands. Additionally, issues such as device compatibility and lack of standardized consumables may limit international scalability. Global expansion also requires navigating regulatory variations and building resilient supply chains to mitigate operational risks.

End-user demand is shifting from passive treatment to active disease management, especially among younger patients who prefer smart monitoring and remote support. Insulin pens are increasingly integrated into digital ecosystems alongside glucose meters and mobile apps, reinforcing the shift toward connected chronic care. Disposable pens, due to their convenience, are seeing rising adoption across hospitals and primary care settings. With global aging trends, demand will grow for insulin pens that offer safety, usability, and traceability, driving the next phase of market evolution.

This report aims to provide a comprehensive presentation of the global market for Insulin Pen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Pen by region & country, by Type, and by Application.

The Insulin Pen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Pen.

Market Segmentation

By Company

• Novo Nordisk
• Eli Lilly
• Sanofi
• Embecta
• MDT Group
• Dongbao
• Owen Mumford
• Ganlee

Segment by Type

• Reusable Insulin Pen
• Disposable Insulin Pen

Segment by Application

• Hospitals
• Clinics
• The Chemist's Shops

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Insulin Pen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Insulin Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Insulin Pen in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Insulin Pen Product Introduction
• 1.2 Global Insulin Pen Market Size Forecast
  • 1.2.1 Global Insulin Pen Sales Value (2020-2031)
  • 1.2.2 Global Insulin Pen Sales Volume (2020-2031)
  • 1.2.3 Global Insulin Pen Sales Price (2020-2031)
• 1.3 Insulin Pen Market Trends & Drivers
  • 1.3.1 Insulin Pen Industry Trends
  • 1.3.2 Insulin Pen Market Drivers & Opportunity
  • 1.3.3 Insulin Pen Market Challenges
  • 1.3.4 Insulin Pen Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Insulin Pen Players Revenue Ranking (2024)
• 2.2 Global Insulin Pen Revenue by Company (2020-2025)
• 2.3 Global Insulin Pen Players Sales Volume Ranking (2024)
• 2.4 Global Insulin Pen Sales Volume by Company Players (2020-2025)
• 2.5 Global Insulin Pen Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Insulin Pen Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Insulin Pen Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Insulin Pen
• 2.9 Insulin Pen Market Competitive Analysis
  • 2.9.1 Insulin Pen Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Pen Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Pen as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Reusable Insulin Pen
  • 3.1.2 Disposable Insulin Pen
• 3.2 Global Insulin Pen Sales Value by Type
  • 3.2.1 Global Insulin Pen Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Insulin Pen Sales Value, by Type (2020-2031)
  • 3.2.3 Global Insulin Pen Sales Value, by Type (%) (2020-2031)
• 3.3 Global Insulin Pen Sales Volume by Type
  • 3.3.1 Global Insulin Pen Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Insulin Pen Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Insulin Pen Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Insulin Pen Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals
  • 4.1.2 Clinics
  • 4.1.3 The Chemist's Shops
• 4.2 Global Insulin Pen Sales Value by Application
  • 4.2.1 Global Insulin Pen Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Insulin Pen Sales Value, by Application (2020-2031)
  • 4.2.3 Global Insulin Pen Sales Value, by Application (%) (2020-2031)
• 4.3 Global Insulin Pen Sales Volume by Application
  • 4.3.1 Global Insulin Pen Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Insulin Pen Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Insulin Pen Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Insulin Pen Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Insulin Pen Sales Value by Region
  • 5.1.1 Global Insulin Pen Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Insulin Pen Sales Value by Region (2020-2025)
  • 5.1.3 Global Insulin Pen Sales Value by Region (2026-2031)
  • 5.1.4 Global Insulin Pen Sales Value by Region (%), (2020-2031)
• 5.2 Global Insulin Pen Sales Volume by Region
  • 5.2.1 Global Insulin Pen Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Insulin Pen Sales Volume by Region (2020-2025)
  • 5.2.3 Global Insulin Pen Sales Volume by Region (2026-2031)
  • 5.2.4 Global Insulin Pen Sales Volume by Region (%), (2020-2031)
• 5.3 Global Insulin Pen Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Insulin Pen Sales Value, 2020-2031
  • 5.4.2 North America Insulin Pen Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Insulin Pen Sales Value, 2020-2031
  • 5.5.2 Europe Insulin Pen Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Insulin Pen Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Insulin Pen Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Insulin Pen Sales Value, 2020-2031
  • 5.7.2 South America Insulin Pen Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Insulin Pen Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Insulin Pen Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Insulin Pen Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Insulin Pen Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Insulin Pen Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Insulin Pen Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Insulin Pen Sales Value, 2020-2031
  • 6.3.2 United States Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Insulin Pen Sales Value, 2020-2031
  • 6.4.2 Europe Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Insulin Pen Sales Value, 2020-2031
  • 6.5.2 China Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Insulin Pen Sales Value, 2020-2031
  • 6.6.2 Japan Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Insulin Pen Sales Value, 2020-2031
  • 6.7.2 South Korea Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Insulin Pen Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Insulin Pen Sales Value, 2020-2031
  • 6.9.2 India Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Insulin Pen Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Novo Nordisk
  • 7.1.1 Novo Nordisk Company Information
  • 7.1.2 Novo Nordisk Introduction and Business Overview
  • 7.1.3 Novo Nordisk Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Novo Nordisk Insulin Pen Product Offerings
  • 7.1.5 Novo Nordisk Recent Development
• 7.2 Eli Lilly
  • 7.2.1 Eli Lilly Company Information
  • 7.2.2 Eli Lilly Introduction and Business Overview
  • 7.2.3 Eli Lilly Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Eli Lilly Insulin Pen Product Offerings
  • 7.2.5 Eli Lilly Recent Development
• 7.3 Sanofi
  • 7.3.1 Sanofi Company Information
  • 7.3.2 Sanofi Introduction and Business Overview
  • 7.3.3 Sanofi Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Sanofi Insulin Pen Product Offerings
  • 7.3.5 Sanofi Recent Development
• 7.4 Embecta
  • 7.4.1 Embecta Company Information
  • 7.4.2 Embecta Introduction and Business Overview
  • 7.4.3 Embecta Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Embecta Insulin Pen Product Offerings
  • 7.4.5 Embecta Recent Development
• 7.5 MDT Group
  • 7.5.1 MDT Group Company Information
  • 7.5.2 MDT Group Introduction and Business Overview
  • 7.5.3 MDT Group Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 MDT Group Insulin Pen Product Offerings
  • 7.5.5 MDT Group Recent Development
• 7.6 Dongbao
  • 7.6.1 Dongbao Company Information
  • 7.6.2 Dongbao Introduction and Business Overview
  • 7.6.3 Dongbao Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Dongbao Insulin Pen Product Offerings
  • 7.6.5 Dongbao Recent Development
• 7.7 Owen Mumford
  • 7.7.1 Owen Mumford Company Information
  • 7.7.2 Owen Mumford Introduction and Business Overview
  • 7.7.3 Owen Mumford Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Owen Mumford Insulin Pen Product Offerings
  • 7.7.5 Owen Mumford Recent Development
• 7.8 Ganlee
  • 7.8.1 Ganlee Company Information
  • 7.8.2 Ganlee Introduction and Business Overview
  • 7.8.3 Ganlee Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Ganlee Insulin Pen Product Offerings
  • 7.8.5 Ganlee Recent Development

8 Industry Chain Analysis

• 8.1 Insulin Pen Industrial Chain
• 8.2 Insulin Pen Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Insulin Pen Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Insulin Pen Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer